IP Group Valuation

Is IPOL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of IPOL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate IPOL's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate IPOL's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for IPOL?

Key metric: As IPOL is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for IPOL. This is calculated by dividing IPOL's market cap by their current book value.
What is IPOL's PB Ratio?
PB Ratio0.4x
BookUK£1.09b
Market CapUK£426.49m

Price to Book Ratio vs Peers

How does IPOL's PB Ratio compare to its peers?

The above table shows the PB ratio for IPOL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average0.6x
GROW Molten Ventures
0.5x91.3%UK£594.5m
ARIX Arix Bioscience
0.7xn/aUK£176.5m
ORIT Octopus Renewables Infrastructure Trust
0.7xn/aUK£399.8m
SIHL Symphony International Holdings
0.4xn/aUS$156.1m
IPOL IP Group
0.4x139.0%UK£426.5m

Price-To-Book vs Peers: IPOL is good value based on its Price-To-Book Ratio (0.4x) compared to the peer average (0.6x).


Price to Book Ratio vs Industry

How does IPOL's PB Ratio compare vs other companies in the GB Capital Markets Industry?

6 CompaniesPrice / BookEstimated GrowthMarket Cap
IX. i(x) Net Zero
0.07xn/aUS$8.94m
TI1 Trian Investors 1
0.006xn/aUS$3.21m
MIL Myanmar Investments International
0.1xn/aUS$1.14m
ASLR Asimilar Group
0.1xn/aUS$878.09k
No. of Companies30PB00.81.62.43.24+
6 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Book vs Industry: IPOL is good value based on its Price-To-Book Ratio (0.4x) compared to the UK Capital Markets industry average (0.9x).


Price to Book Ratio vs Fair Ratio

What is IPOL's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

IPOL PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio0.4x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate IPOL's Price-To-Book Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst IPOL forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUK£0.43
UK£1.13
+160.1%
11.5%UK£1.26UK£1.00n/a2
Nov ’25UK£0.46
UK£1.13
+146.7%
11.5%UK£1.26UK£1.00n/a2
Oct ’25UK£0.50
UK£1.13
+127.1%
11.5%UK£1.26UK£1.00n/a2
Sep ’25UK£0.42
UK£1.13
+168.7%
11.5%UK£1.26UK£1.00n/a2
Aug ’25UK£0.43
UK£1.13
+164.0%
11.5%UK£1.26UK£1.00n/a2
Jul ’25UK£0.43
UK£1.13
+164.3%
11.5%UK£1.26UK£1.00n/a2
Jun ’25UK£0.54
UK£1.13
+107.7%
11.5%UK£1.26UK£1.00n/a2
May ’25UK£0.47
UK£1.28
+170.6%
1.6%UK£1.30UK£1.26n/a2
Apr ’25UK£0.48
UK£1.28
+168.2%
1.6%UK£1.30UK£1.26n/a2
Mar ’25UK£0.49
UK£1.32
+168.4%
1.1%UK£1.33UK£1.30n/a2
Feb ’25UK£0.53
UK£1.32
+148.6%
1.1%UK£1.33UK£1.30n/a2
Jan ’25UK£0.58
UK£1.32
+126.7%
1.1%UK£1.33UK£1.30n/a2
Dec ’24UK£0.51
UK£1.32
+160.4%
1.1%UK£1.33UK£1.30n/a2
Nov ’24UK£0.44
UK£1.32
+195.8%
1.1%UK£1.33UK£1.30UK£0.462
Oct ’24UK£0.53
UK£1.18
+122.9%
16.7%UK£1.33UK£0.90UK£0.503
Sep ’24UK£0.58
UK£1.18
+102.2%
16.7%UK£1.33UK£0.90UK£0.423
Aug ’24UK£0.60
UK£1.18
+95.8%
16.7%UK£1.33UK£0.90UK£0.433
Jul ’24UK£0.57
UK£1.18
+106.8%
16.7%UK£1.33UK£0.90UK£0.433
Jun ’24UK£0.56
UK£1.22
+120.0%
19.5%UK£1.47UK£0.90UK£0.543
May ’24UK£0.56
UK£1.22
+118.1%
19.5%UK£1.47UK£0.90UK£0.473
Apr ’24UK£0.55
UK£1.22
+121.0%
19.5%UK£1.47UK£0.90UK£0.483
Mar ’24UK£0.66
UK£1.29
+96.0%
11.7%UK£1.47UK£1.10UK£0.493
Feb ’24UK£0.61
UK£1.29
+110.4%
11.7%UK£1.47UK£1.10UK£0.533
Jan ’24UK£0.56
UK£1.29
+130.4%
11.7%UK£1.47UK£1.10UK£0.583
Dec ’23UK£0.67
UK£1.32
+97.5%
12.0%UK£1.47UK£1.10UK£0.513
Nov ’23UK£0.63
UK£1.32
+110.9%
12.0%UK£1.47UK£1.10UK£0.443

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies